Abstract:Angiotensin II (Ang II) is an octapeptide with a central role in cardiovascular homeostasis and actions in several organs including the adrenal gland, kidney, brain, heart, smooth muscle cells and sympathetic nervous system. At these levels it is involved in cellular proliferation and apoptosis, cellular migration, inflammation, synthesis and release of various mediators such as platelet-derived growth factor and endothelin-1) and in the synthesis of extracellular matrix. Traditionally, Ang II was considered a systemic hormone regulating blood pressure, aldosterone release and sodium reabsorption. However, nowadays it is known that this mediator is also formed at the tissue level in the brain, kidney and heart, suggesting local paracrine and autocrine action. At the vascular level, with the exception of renin, all other components of this system are locally produced in vascular adventitia, smooth muscle cells or endothelial cells. In the heart all the components have also been found and their response to humoral, nervous and mechanical stimuli suggests a working local system. Ang II exerts its biological action through two main receptor subtypes: AT-1 and AT-2. The AT-1 receptor is responsible for many of the physiological effects of Ang II in cardiac, vascular, kidney, brain and endocrine cells. Expression of the AT-2 receptor is higher in fetal tissue, especially in mesenchymal tissue (like the tongue, endoderm and diaphragm), decreasing after birth. Its effects are frequently opposite to those mediated bt the AT-1 receptor. Its role in cardiovascular pathophysiology is not yet established. Ang II recruits a complex cascade of intracellular second messengers with different patterns of temporal activation: immediate (in seconds), early (in minutes) and late (in hours). Clinical trials using angiotensin converting enzyme inhibitors (ACEi) and AT-1 receptor antagonists (ARA) have shown improvement in morbidity and mortality in hypertension, congestive heart failure and after myocardial infarction. Although many of the mechanisms underlying these actions are not fully understood, there are no doubts about the beneficial effects of inhibiting this system in the treatment of several cardiovascular diseases.

Advances in Research into Cardiovascular Effect of Angiotensin II Type 2 Receptor

Angiotensin II type-2 receptor-specific effects on the cardiovascular system.

[Effects of Angiotensin Converting Enzyme Inhibitor on the Expression of Angiotensin Converting Enzyme 2 in Atrium of Patients with Atrial Fibrillation].

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Role of Angiotensin AT1 and AT2 Receptors in Cardiac Hypertrophy and Cardiac Remodelling.

Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling

Advances in Research on Structure-activity Relationship of Selective AngiotensinⅡ AT_2 Receptor Agonists

The angiotensin II type 2 receptor for pain control

Research and Development of the New Drugs Acting on Angiotensin II Receptor

Latest findings on the prevention of cardiovascular events - Focus on the AT 1 receptor

[Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]

The Relationship of the Two Subtypes of Angioensin II Receptor

[Role of AT2 Receptors on Angiotensin II-induced Tumor Necrosis Factor Alpha and Interleukin 1 Beta Secretion in Adult Rat Cardiac Fibroblasts].

Metoprolol Restores Expression and Vasodilatation Function of AT2R in Spontaneously Hypertensive Rats

Angiotensin Iv Protects Against Angiotensin Ii-Induced Cardiac Injury Via At4 Receptor

AT2 Receptor Signaling and Sympathetic Regulation

Effect of Angiotensin II Receptor 1 Antisense Oligodoexynucleotides on Physiological and Pathophysiological Growth of Cardiomyocytes.

Inhibitory effect of antisense oligonucleotides of angiotensin Ⅱ receptor 1 on expression of atrial natriuretic factor induced by angiotensin Ⅱ in cardiomyocytes

Investigation on AngiotensinⅡTypeⅠReceptor Antisense Oligonucleotide in Reversing Cardiac Myocytes Hypertrophy

Angiotensin Ⅱ type 2 receptors participate in the regulation of inflammatory cytokine secretion in adult rat hypertrophied cardiomyocytes

The Signalling of At2 and the Influence on the Collagen Metabolism of At2 Receptor in Adult Rat Cardiac Fibroblasts